Načítá se...
MeCP2 mutations: progress towards understanding and treating Rett syndrome
Rett syndrome is a profound neurological disorder caused by mutations in the MECP2 gene, but preclinical research has indicated that it is potentially treatable. Progress towards this goal depends on the development of increasingly relevant model systems and on our improving knowledge of MeCP2 funct...
Uloženo v:
| Vydáno v: | Genome Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5316219/ https://ncbi.nlm.nih.gov/pubmed/28212680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0411-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|